Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1981 Nov;12(5):637–645. doi: 10.1111/j.1365-2125.1981.tb01282.x

Theophylline pharmacokinetics in advanced age.

E J Antal, P A Kramer, S A Mercik, D J Chapron, I R Lawson
PMCID: PMC1401974  PMID: 7332727

Abstract

1 Theophylline kinetics following a single oral dose were characterized and compared in non-institutionalized ambulatory elderly and young gender-matched control subjects. Study design stressed stringent, yet realistic, control of several external factors known to influence theophylline metabolism. 2 Plasma levels of total drug were significantly higher in the elderly only at early sampling times (0.5 and 1 h) and at 36 h, while unbound theophylline levels were significantly higher (P less than 0.05) at all sampling times resulting in a 45% greater AUC for unbound drug. 3 While no significant differences in volume of distribution (Vd) or overall plasma clearance were observed when calculations were based on total plasma theophylline, a 37% reduction in Vd (P less than 0.005) and a 30% reduction in overall plasma clearance (P less than 0.02) in the elderly became apparent when plasma protein binding was taken into account. 4 When urinary excretion patterns were compared, the elderly were found to have excreted a significantly higher fraction of the recovered dose as 1-methyluric acid (P less than 0.01) and a lower fraction as unchanged theophylline (P less than 0.02). A 47% reduction in the renal clearance of unbound theophylline (P less than 0.005) was also observed in the elderly. 5 Results were consistent with less viable metabolism and renal excretion pathways for theophylline elimination in the elderly and serve to reemphasize the importance of including an assessment of plasma protein binding in studies of drug disposition in the elderly.

Full text

PDF
637

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cusack B., Kelly J. G., Lavan J., Noel J., O'Malley K. Theophylline kinetics in relation to age: the importance of smoking. Br J Clin Pharmacol. 1980 Aug;10(2):109–114. doi: 10.1111/j.1365-2125.1980.tb01726.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Greenblatt D. J., Shader R. I. Effects of age and other drugs on benzodiazepine kinetics. Arzneimittelforschung. 1980;30(5A):886–890. [PubMed] [Google Scholar]
  3. Grygiel J. J., Wing L. M., Farkas J., Birkett D. J. Effects of allopurinol on theophylline metabolism and clearance. Clin Pharmacol Ther. 1979 Nov;26(5):660–667. doi: 10.1002/cpt1979265660. [DOI] [PubMed] [Google Scholar]
  4. Hurwitz N. Predisposing factors in adverse reactions to drugs. Br Med J. 1969 Mar 1;1(5643):536–539. doi: 10.1136/bmj.1.5643.536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Jusko W. J., Koup J. R., Vance J. W., Schentag J. J., Kuritzky P. Intravenous theophylline therapy: nomogram guidelines. Ann Intern Med. 1977 Apr;86(4):400–404. doi: 10.7326/0003-4819-86-4-400. [DOI] [PubMed] [Google Scholar]
  6. Lohmann S. M., Miech R. P. Theophylline metabolism by the rat liver microsomal system. J Pharmacol Exp Ther. 1976 Jan;196(1):213–225. [PubMed] [Google Scholar]
  7. Miksic J. R., Hodes B. Eliminating 1,7-dimethylxanthine interference from reversed-phase liquid-chromatographic analysis for theophylline. Clin Chem. 1979 Oct;25(10):1866–1867. [PubMed] [Google Scholar]
  8. Ogilvie R. I. Clinical pharmacokinetics of theophylline. Clin Pharmacokinet. 1978 Jul-Aug;3(4):267–293. doi: 10.2165/00003088-197803040-00002. [DOI] [PubMed] [Google Scholar]
  9. Sedman A. J., Wagner J. G. CSTRIP, a fortran IV computer program for obtaining initial polyexponential parameter estimates. J Pharm Sci. 1976 Jul;65(7):1006–1010. doi: 10.1002/jps.2600650713. [DOI] [PubMed] [Google Scholar]
  10. Shah V. P., Wallace S. M., Riegelman S. Microultrafiltration technique for drug-protein binding determination in plasma. J Pharm Sci. 1974 Sep;63(9):1364–1367. doi: 10.1002/jps.2600630905. [DOI] [PubMed] [Google Scholar]
  11. Sheehan M., Haythorn P. Rapid gas chromatographic determination of underivatized theophylline in whole blood. J Chromatogr. 1976 Feb 18;117(2):392–398. doi: 10.1016/0021-9673(76)80016-7. [DOI] [PubMed] [Google Scholar]
  12. Swift C. G., Homeida M., Halliwell M., Roberts C. J. Antipyrine disposition and liver size in the elderly. Eur J Clin Pharmacol. 1978 Nov 16;14(2):149–152. doi: 10.1007/BF00607447. [DOI] [PubMed] [Google Scholar]
  13. Upton R. A., Sansom L., Guentert T. W., Powell J. R., Thiercelin J. F., Shah V. P., Coates P. E., Riegelman S. Evaluation of the absorption from 15 commercial theophylline products indicating deficiencies in currently applied bioavailability criteria. J Pharmacokinet Biopharm. 1980 Jun;8(3):229–242. doi: 10.1007/BF01059644. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES